Biomimetic Polymer-Based Method for Selective Capture of C-Reactive Protein in Biological Fluids
Source abstract
Abstract
Selective capturing and purification of C-reactive protein (CRP) from complex biological fluids plays a pivotal role in studying biological activities of CRP in various diseases. However, obvious nonspecific adsorption of proteins was observed on current affinity sorbents, and thus additional purification steps are often required, which could compromise the recovery of the target protein and/or introduce new impurities. In this study, inspired by the highly specific interaction between CRP and the cell membrane, an excellent anti-biofouling compound 2-(methacryloyloxy)ethyl phosphorylcholine and a highly hydrophilic crosslinker N, N'-methylenebisacrylamide were employed to fabricate a novel cell membrane biomimetic polymer for selective capture of CRP in the presence of calcium ions. Based on the polymer described above, a facile enrichment approach was established after systematic optimization of the washing and elution conditions. With its favorable properties, such as good porosity, weak electrostatic interaction, high hydrophilicity, and biocompatibility, the novel biomimetic polymer exhibits good specificity, selectivity, recovery (near 100%), purity (95%), and a lower nonspecific protein adsorption for CRP in comparison with commercial immobilized p-aminophenyl phosphoryl choline gel and other purification materials. Furthermore, the structural integrity and functionality of CRP in the elution fraction were well preserved and confirmed by circular dichroism spectroscopy, fluorescence spectroscopy, and immunoturbidimetric assay. Finally, the biomimetic polymer was successfully applied to the selective enrichment of CRP from sera of patients with inflammation and rats. The proposed novel enrichment approach based on the versatile biomimetic polymer can be used for effective CRP purification, which will benefit the in-depth study of its biological roles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery · Platelet Disorders and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
Laboratory of Analytical Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, CIRM, University of Liege, CHU B36, B-4000 Liege, Belgium
Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo 315211, China
Funding
China Postdoctoral Science Foundation · National Natural Science Foundation of China
References (54)
Show source-provided references
1. 10.1038/ncomms1418810.1038/ncomms14188 ↗
2. 10.1002/app.4176610.1002/app.41766 ↗
3. 10.1038/ni.192310.1038/ni.1923 ↗
4. 10.1016/j.actbio.2016.10.04310.1016/j.actbio.2016.10.043 ↗
5. 10.1007/s12026-013-8384-010.1007/s12026-013-8384-0 ↗
6. Marnell L. L. · J. Immunol. · 1995 · 155 · 218510.4049/jimmunol.155.4.2185 ↗
7. 10.1016/j.biotechadv.2015.12.01010.1016/j.biotechadv.2015.12.010 ↗
8. 10.1021/acs.analchem.6b0142710.1021/acs.analchem.6b01427 ↗
9. 10.1021/ac502326510.1021/ac5023265 ↗
10. 10.1039/C7TB00637C10.1039/C7TB00637C ↗
11. 10.1038/nature0467210.1038/nature04672 ↗
12. 10.1016/j.jim.2012.07.01310.1016/j.jim.2012.07.013 ↗
13. 10.1093/intimm/dxl02310.1093/intimm/dxl023 ↗
14. 10.1002/jcla.186001010410.1002/jcla.1860010104 ↗
15. 10.1016/j.aca.2004.12.07410.1016/j.aca.2004.12.074 ↗
16. 10.1080/01496395.2013.80751610.1080/01496395.2013.807516 ↗
17. Caspi D. · Immunology · 1984 · 53 · 307
18. 10.1016/0165-2427(93)90026-Z10.1016/0165-2427(93)90026-Z ↗
19. 10.1016/0165-2427(92)90103-W10.1016/0165-2427(92)90103-W ↗
20. 10.1016/j.fsi.2008.03.01510.1016/j.fsi.2008.03.015 ↗
21. 10.1016/j.nantod.2010.12.00910.1016/j.nantod.2010.12.009 ↗
22. 10.1021/ja501770y10.1021/ja501770y ↗
23. 10.1021/jacs.5b1315610.1021/jacs.5b13156 ↗
24. 10.1039/C3TB21493A10.1039/C3TB21493A ↗
25. 10.1002/elps.20130026010.1002/elps.201300260 ↗
26. 10.1038/nmat123310.1038/nmat1233 ↗
27. 10.1088/1468-6996/13/6/06410110.1088/1468-6996/13/6/064101 ↗
28. 10.1021/acsami.7b0269610.1021/acsami.7b02696 ↗
29. 10.1021/ac501322x10.1021/ac501322x ↗
30. 10.1039/c002239j10.1039/c002239j ↗
31. 10.1016/j.biomaterials.2009.11.09510.1016/j.biomaterials.2009.11.095 ↗
32. 10.1021/acsami.6b0607110.1021/acsami.6b06071 ↗
33. 10.1016/j.aca.2017.11.03210.1016/j.aca.2017.11.032 ↗
34. 10.1016/j.aca.2018.02.01210.1016/j.aca.2018.02.012 ↗
35. 10.1016/j.chroma.2016.11.04610.1016/j.chroma.2016.11.046 ↗
36. 10.1016/j.chroma.2015.06.05610.1016/j.chroma.2015.06.056 ↗
37. 10.1016/j.aca.2017.10.02110.1016/j.aca.2017.10.021 ↗
38. 10.1021/bm700728k10.1021/bm700728k ↗
39. 10.1016/S0969-2126(99)80023-910.1016/S0969-2126(99)80023-9 ↗
40. 10.4049/jimmunol.169.6.321710.4049/jimmunol.169.6.3217 ↗
41. 10.1016/j.chroma.2011.12.07410.1016/j.chroma.2011.12.074 ↗
42. 10.1002/biot.20120032810.1002/biot.201200328 ↗
43. 10.1016/j.aca.2006.03.09610.1016/j.aca.2006.03.096 ↗
44. 10.1016/j.fsi.2010.01.00710.1016/j.fsi.2010.01.007 ↗
45. 10.1016/j.dci.2008.04.00410.1016/j.dci.2008.04.004 ↗
46. 10.1084/jem.142.5.106510.1084/jem.142.5.1065 ↗
47. 10.1016/0022-1759(78)90203-X10.1016/0022-1759(78)90203-X ↗
48. 10.1016/0014-5793(78)80167-710.1016/0014-5793(78)80167-7 ↗
49. 10.1006/prep.1994.102410.1006/prep.1994.1024 ↗
50. 10.1021/acsami.6b1473310.1021/acsami.6b14733 ↗
51. 10.1016/j.pep.2006.07.00910.1016/j.pep.2006.07.009 ↗
52. 10.1039/c2sm25779c10.1039/c2sm25779c ↗
53. 10.1111/j.1747-0285.2006.00342.x10.1111/j.1747-0285.2006.00342.x ↗
54. 10.1021/ac901597h10.1021/ac901597h ↗